Literature DB >> 3754199

The gene for clotting factor 10 is mapped to 13q32----qter.

N J Royle, M R Fung, R T MacGillivray, J L Hamerton.   

Abstract

The structural gene for the human clotting factor 10 (F10) has been mapped to chromosome 13 with a cDNA probe hybridized to DNAs from a panel of human X hamster hybrids. In situ hybridization was used to assign F10 to region 13q32----qter of chromosomes from normal human lymphocytes.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3754199     DOI： 10.1159/000132225

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN： 0301-0171


  4 in total

1.  Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.

Authors:  K Wieland; D S Millar; C B Grundy; R S Mibashan; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

2.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

3.  Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples.

Authors:  L C Murphy; H Dotzlaw; J Hamerton; J Schwarz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.

Authors:  H H Watzke; A Wallmark; N Hamaguchi; P Giardina; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.